[Treatment of vascular headaches].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000150:complications*; D003000:Clonidine / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use; D008784:Methysergide / Q000627:therapeutic use; D010615:Phenacetin / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011247:Pregnancy; D019966:Substance-Related Disorders; D014653:Vascular Headaches / Q000188:drug therapy / Q000209:etiology
D000319:Adrenergic beta-Antagonists; D006728:Hormones; D006827:Hydantoins; D010919:Placebos; D002220:Carbamazepine; D010615:Phenacetin; D003000:Clonidine; D004878:Ergotamine; D008784:Methysergide
Zur Behandlung vaskulärer Kopfschmerzen.